Abstract
Background: Clozapine induced granulocytopenia has gained wide attention and effective monitoring has been able to prevent a number of untoward deaths. However, other myelodysplasias induced by Clozapine are still unrecognized and unreported. Another clinical complication of Clozapine is eosinophilia. However, this entity is unrecognized as the focus is mostly on granulocytopenia and neutropenia.
Objective: To describe a case of Clozapine induced eosinophilia without any other clinical or biochemical abnormalities induced by Clozapine.
Methodology: The file records of a patient with Schizoaffective disorder who developed eosinophilia while receiving Clozapine were studied and analyzed.
Results: The patient with Schizoaffective disorder who was on Clozapine with stringent monitoring developed eosinophilia with eosinophil counts rising up to 2850, with a fall in neutrophil counts up to 2320, all of which was reversed after stopping Clozapine.
Conclusion: Clozapine induced eosinophilia should also be considered as one of the important side effects along with neutropenia and leukopenia. Along with neutropenia and leukopenia it might be a manifestation of undergoing immunological abnormality associated with Clozapine.
Keywords: Agranulocytosis, clozapine, eosinophilia, neutropenia, schizoaffective disorder, second generation antipsychotics.
Current Psychopharmacology
Title:Clozapine Induced Eosinophilia in a Case of Schizoaffective Disorder
Volume: 5
Author(s): Deepak Moyal, Amit Khanna, Vishal Dhiman and Aninda Sidana
Affiliation:
Keywords: Agranulocytosis, clozapine, eosinophilia, neutropenia, schizoaffective disorder, second generation antipsychotics.
Abstract: Background: Clozapine induced granulocytopenia has gained wide attention and effective monitoring has been able to prevent a number of untoward deaths. However, other myelodysplasias induced by Clozapine are still unrecognized and unreported. Another clinical complication of Clozapine is eosinophilia. However, this entity is unrecognized as the focus is mostly on granulocytopenia and neutropenia.
Objective: To describe a case of Clozapine induced eosinophilia without any other clinical or biochemical abnormalities induced by Clozapine.
Methodology: The file records of a patient with Schizoaffective disorder who developed eosinophilia while receiving Clozapine were studied and analyzed.
Results: The patient with Schizoaffective disorder who was on Clozapine with stringent monitoring developed eosinophilia with eosinophil counts rising up to 2850, with a fall in neutrophil counts up to 2320, all of which was reversed after stopping Clozapine.
Conclusion: Clozapine induced eosinophilia should also be considered as one of the important side effects along with neutropenia and leukopenia. Along with neutropenia and leukopenia it might be a manifestation of undergoing immunological abnormality associated with Clozapine.
Export Options
About this article
Cite this article as:
Moyal Deepak, Khanna Amit, Dhiman Vishal and Sidana Aninda, Clozapine Induced Eosinophilia in a Case of Schizoaffective Disorder, Current Psychopharmacology 2016; 5 (1) . https://dx.doi.org/10.2174/2211556005666160310001856
DOI https://dx.doi.org/10.2174/2211556005666160310001856 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Circulating Advanced Oxidation Protein Products as Oxidative Stress Biomarkers and Progression Mediators in Pathological Conditions Related to Inflammation and Immune Dysregulation
Current Medicinal Chemistry Perspectives on Medicinal Properties of Mangiferin
Mini-Reviews in Medicinal Chemistry The Effect of SEX/Gender on Cardiovascular Pharmacology
Current Pharmaceutical Design Transgenic Models in Allergic Responses
Current Drug Targets Editorial [Hot Topic:Anti-Inflammatory Strategy: Old Ally or New Promise in Therapy (Guest Editor: Marcella Reale)]
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry A3 Receptor Ligands: Past, Present and Future Trends
Current Topics in Medicinal Chemistry Novel Adjunctive Therapies for the Treatment of Tuberculosis
Current Molecular Medicine Review of the Biological Activity of Maslinic Acid
Current Drug Targets Neurocysticercosis: The Enigmatic Disease
Central Nervous System Agents in Medicinal Chemistry Lycopene and Cardiovascular Diseases: An Update
Current Medicinal Chemistry Models to Study Atherosclerosis: A Mechanistic Insight
Current Vascular Pharmacology Free Radicals and Antioxidants: How to Reestablish Redox Homeostasis in Chronic Diseases?
Current Medicinal Chemistry Patterns of Self-Medication with Medicinal Plants and Related Adverse Events - A South American Survey
Current Drug Safety Angiotensin 1-7 Promotes Cardiac Angiogenesis Following Infarction
Current Vascular Pharmacology Antileukotriene Drugs: Clinical Application, Effectiveness and Safety
Current Medicinal Chemistry The Interplay between Cofilin and Phospho-Cofilin: Its Role in Maintaining Blood Brain Barrier Integrity
CNS & Neurological Disorders - Drug Targets Angiogenesis in Chronic Lymphocytic Leukemia
Current Angiogenesis (Discontinued) Epigenetic Modulation: A Promising Avenue to Advance Hematopoietic Stem Cell-Based Therapy for Severe Autoimmune Disorders
Epigenetic Diagnosis & Therapy (Discontinued) Leptin and Vascular Smooth Muscle Cells
Current Pharmaceutical Design Protective Effects of Astaxanthin on Nephrotoxicity in Rats with Induced Renovascular Occlusion
Combinatorial Chemistry & High Throughput Screening